|

Ivosidenib Oral Tablet Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Servier Bio-Innovation LLC1
  • Servier Affaires Médicales1

Indications

  • Cancer2
  • IDH1-Mutated Malignancies1
  • Cholangiocarcinoma1

Other1 trial

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Phase 3

Atlanta, Georgia1 trial

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Emory University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.